Autolus Therapeutics to Report First Quarter 2022 Financial Results and Host Conference Call on May 5
Autolus Therapeutics plc (Nasdaq: AUTL) will report its Q1 2022 financial results and operational highlights on May 5, 2022, before U.S. markets open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Autolus Therapeutics plc (Nasdaq: AUTL) will report its Q1 2022 financial results and operational highlights on May 5, 2022, before U.S. markets open. A conference call and webcast will follow at 8:30 am ET/1:30 pm BST for management to discuss the results and provide a business update. Investors can access the presentation and call via Autolus' website or by dialing provided numbers for U.S. and international listeners. The call will be available for replay for one week.
Positive
- Upcoming Q1 2022 financial results release expected to provide insights into operational progress.
Negative
- None.
Details
News Market Reaction – AUTL
The recorded move for AUTL in the trading session of this news was +2.92%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LONDON, April 25, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its first quarter 2022 financial results and operational highlights before open of U.S. markets on Thursday, May 5, 2022.
Management will host a conference call and webcast at 8:30 am ET/1:30 pm BST to discuss the company’s financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to the events section of Autolus’ website.
The call may also be accessed by dialing (866) 679-5407 for U.S. and Canada callers or (409) 217-8320 for international callers. Please reference conference ID 3245616. After the conference call, a replay will be available for one week. To access the replay, please dial (855) 859-2056 for U.S. and Canada callers or (404) 537-3406 for international callers. Please reference conference ID 3245616.
Contact:
Olivia Manser
+44 (0) 7780 471568
o.manser@autolus.com
Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com
Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303
susan@sanoonan.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.